Citadel Advisors’s Coherus Oncology CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $204K | Buy |
121,000
+100,000
| +476% | +$178K | ﹤0.01% | 11371 |
|
|
2025
Q4 | $29.8K | Sell |
21,000
-98,700
| -82% | -$144K | ﹤0.01% | 12226 |
|
|
2025
Q3 | $196K | Buy |
119,700
+88,700
| +286% | +$98.7K | ﹤0.01% | 11285 |
|
|
2025
Q2 | $22.7K | Sell |
31,000
-34,300
| -53% | -$29.6K | ﹤0.01% | 12077 |
|
|
2025
Q1 | $52.7K | Sell |
65,300
-26,500
| -29% | -$30.5K | ﹤0.01% | 12262 |
|
|
2024
Q4 | $127K | Buy |
91,800
+52,300
| +132% | +$58.7K | ﹤0.01% | 11111 |
|
|
2024
Q3 | $41.1K | Sell |
39,500
-11,400
| -22% | -$15.6K | ﹤0.01% | 12122 |
|
|
2024
Q2 | $88.1K | Sell |
50,900
-34,700
| -41% | -$69.8K | ﹤0.01% | 11095 |
|
|
2024
Q1 | $205K | Sell |
85,600
-38,384
| -31% | -$94.5K | ﹤0.01% | 10279 |
|
|
2023
Q4 | $413K | Buy |
123,984
+69,684
| +128% | +$187K | ﹤0.01% | 8502 |
|
|
2023
Q3 | $203K | Buy |
54,300
+14,100
| +35% | +$65.1K | ﹤0.01% | 9883 |
|
|
2023
Q2 | $172K | Buy |
40,200
+32,600
| +429% | +$192K | ﹤0.01% | 10119 |
|
|
2023
Q1 | $52K | Sell |
7,600
-31,400
| -81% | -$244K | ﹤0.01% | 12097 |
|
|
2022
Q4 | $309K | Buy |
+39,000
| New | +$300K | ﹤0.01% | 9254 |
|
|
2021
Q4 | – | Sell |
-14,100
| Closed | -$227K | – | 13860 |
|
|
2021
Q3 | $227K | Sell |
14,100
-11,200
| -44% | -$164K | ﹤0.01% | 11700 |
|
|
2021
Q2 | $350K | Buy |
25,300
+400
| +2% | +$5.67K | ﹤0.01% | 10890 |
|
|
2021
Q1 | $364K | Buy |
24,900
+9,800
| +65% | +$166K | ﹤0.01% | 10394 |
|
|
2020
Q4 | $262K | Buy |
+15,100
| New | +$269K | ﹤0.01% | 9298 |
|
|
2020
Q2 | – | Sell |
-10,300
| Closed | -$167K | – | 9834 |
|
|
2020
Q1 | $167K | Sell |
10,300
-5,300
| -34% | -$97.9K | ﹤0.01% | 8185 |
|
|
2019
Q4 | $281K | Buy |
15,600
+5,600
| +56% | +$103K | ﹤0.01% | 7680 |
|
|
2019
Q3 | $203K | Sell |
10,000
-1,900
| -16% | -$38K | ﹤0.01% | 8134 |
|
|
2019
Q2 | $263K | Buy |
+11,900
| New | +$207K | ﹤0.01% | 7783 |
|
|
2019
Q1 | – | Sell |
-17,100
| Closed | -$155K | – | 9300 |
|
|
2018
Q4 | $155K | Sell |
17,100
-2,700
| -14% | -$31.2K | ﹤0.01% | 8035 |
|
|
2018
Q3 | $327K | Buy |
+19,800
| New | +$351K | ﹤0.01% | 7428 |
|
|
2017
Q3 | – | Sell |
-11,500
| Closed | -$165K | – | 7568 |
|
|
2017
Q2 | $165K | Buy |
+11,500
| New | +$221K | ﹤0.01% | 6674 |
|
Other funds holding CHRS
VCM
SB
KKRC
CM
CWG